Therapeutic implication of molecular profiling in patients with non – small cell lung cancer (original) (raw)
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
carlos barrios
2011
View PDFchevron_right
The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC: Figure 1
Kathy Gately
Journal of Clinical Pathology, 2011
View PDFchevron_right
Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation (Review)
Laura Capelli, Paola Ulivi
Molecular and Clinical Oncology, 2013
View PDFchevron_right
A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer
Frances Shepherd
Journal of Thoracic Oncology, 2011
View PDFchevron_right
Current Status of Targeted Therapy in Non Small Cell Lung Cancer (NSCLC)
Dinah Parums
View PDFchevron_right
The role of molecular analyses in the era of personalized therapy for advanced NSCLC
Nicholas Pastis
Lung Cancer, 2012
View PDFchevron_right
Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies
Tianhong Li
Journal of Clinical Oncology, 2013
View PDFchevron_right
Diagnostic, Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
Jelena Knežević
Journal of Personalized Medicine
View PDFchevron_right
Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy
Kelly Domvri, Lutz Freitag
Journal of Cancer, 2013
View PDFchevron_right
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer
Leticia G. León
Frontiers in Bioscience, 2011
View PDFchevron_right
Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancer
Raffaele Ardito, Alfredo Tartarone
Medical Oncology, 2011
View PDFchevron_right
Non-small cell lung cancer - Genetic predictors
Jiri Drabek, Radek Trojanec
2013
View PDFchevron_right
Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non–Small-Cell Lung Cancer (NSCLC)
Saravut Weroha, Thanyanan Reungwetwattana
Clinical Lung Cancer, 2012
View PDFchevron_right
Determinants of Survival in Advanced Non–Small-Cell Lung Cancer in the Era of Targeted Therapies
Tracey Evans
Clinical Lung Cancer, 2013
View PDFchevron_right
Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)
Mao Mao
Oncotarget, 2016
View PDFchevron_right
EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10)
lucia santome
Cancer Management and Research, 2016
View PDFchevron_right
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
Jose Rodriguez
2009
View PDFchevron_right
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
Kenneth O'Byrne
Pharmaceuticals, 2020
View PDFchevron_right
Non-small cell lung cancer: the era of targeted therapy
Mara Antonoff
Lung Cancer: Targets and Therapy, 2012
View PDFchevron_right
Other novel molecular targets in non-small cell lung cancer: it’s not all about EGFR
Brett Hughes
View PDFchevron_right
Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer
Athanasios Pallis
British journal of cancer, 2011
View PDFchevron_right
Molecular pathology of lung cancer: key to personalized medicine
Antonio Lopez-beltran
Modern Pathology, 2012
View PDFchevron_right
Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer
Nir Peled
Therapeutic advances in medical oncology, 2009
View PDFchevron_right
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy
Anais Del Curatolo, Ursula C cesta Incani, Italia Falcone
Expert Opinion on Drug Discovery, 2013
View PDFchevron_right
Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
Venceslau Hespanhol
Archivos de bronconeumologia, 2017
View PDFchevron_right